Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease Read more about Use Of STAT3 Inhibitors In The Prevention Of Mast Cell-mediated Allergic Disease Switzerland14826325.4Filed on 2014-07-18
Zika Viral Antigen Constructs Read more about Zika Viral Antigen Constructs US Patent 11,780,885Filed on 2019-05-16
RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES Read more about RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS STRAINS WITH MUTATIONS IN THE M2-2 ORF PROVIDING A RANGE OF ATTENUATION PHENOTYPES US Patent 11,332,721Filed on 2020-05-18
RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 1 (HPIV1) EXPRESSING A CHIMERIC RSV/HPIV1 F PROTEIN AND USES THEREOF Read more about RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 1 (HPIV1) EXPRESSING A CHIMERIC RSV/HPIV1 F PROTEIN AND USES THEREOF US Patent 11,591,372Filed on 2020-05-18
NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE US Patent 11,976,109Filed on 2020-07-01
NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE Read more about NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE European Patent18840136.8Filed on 2018-12-31
USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS Read more about USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US Application 16/848,587Filed on 2020-04-14
Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Read more about Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection Singapore10202003467RFiled on 2020-04-16
DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS Read more about DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS US Patent 11,332,722Filed on 2020-06-25
CD47-targeted Therapies For The Treatment Of Infectious Disease Read more about CD47-targeted Therapies For The Treatment Of Infectious Disease Turkey17194591.8Filed on 2017-10-03